Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06698536 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff

Study acronym: COYOTE2024
StatusRecruiting
PhaseNot applicable
SponsorAktiia SA
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Feb 28, 2025 to Dec 31, 2026 Completion date: Dec 31, 2025 to Dec 31, 2026v4 Show 1 more changeShow less
    • Completion date: Dec 31, 2025 to Dec 31, 2026
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Primary completion date: Jan 31, 2025 to Feb 28, 2025 · Start date: Dec 2, 2024 to Dec 20, 2024v2 Show 3 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Jan 31, 2025 to Feb 28, 2025
    • Start date: Dec 2, 2024 to Dec 20, 2024
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aktiia SA
9 trials monitored
See all monitored trials
Hypertension
1,795 trials monitored
See 85 trials at risk
The present study, OBPM\_COYOTE2024, with N = 255 participants minimum over 1 visit (lasting \~15min), has been designed to collect raw optical data with Aktiia.product-G2C Clinical investigational device together with Aktiia G2 Bracelet and Aktiia Init I1 oscillometric cuff within a cohort of subjects characterized by a wide variety of phenotypes. The resulting dataset will support research and development activities conducted by AKTIIA SA out of the study context.
Trial Details
NCT Number NCT06698536
Lead Sponsor Aktiia SA
Conditions Hypertension
Enrollment 255 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov